FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1567355673> ?p ?o ?g. }

• W1567355673 endingPage "120" @default.
• W1567355673 startingPage "119" @default.
• W1567355673 abstract "Sir, The postoperative recovery period after vitreoretinal surgery can be quite painful and the degree of pain experienced is often related to the duration of the surgical procedure (Fekrat et al. 2001). Secondary analgesia has been noted to be necessary after subtenon ocular anaesthesia (Kwok et al. 1999). However, little has been written about subtenon infiltration analgesia given at the end of vitreoretinal surgical procedures. Subtenon infiltration of local anaesthetic is a relatively safe and easy procedure (Kwok et al. 1999). Hence we designed a prospective, randomized, double-blind pilot study to assess the efficacy of subtenon Bupivacaine 0.75% infiltration analgesia when used at the end of a surgical procedure to control postoperative pain. All patients undergoing vitreoretinal surgery under a standardized general anaesthetic, between January and April 2002, were selected. All the patients had pre-emptive analgesia with intramuscular Ketoprofen. They were told that they may or may not receive an injection of a pain-killing substance on completion of the surgical procedure and informed consent was obtained. Each patient was assigned to receive either 3 ml of Bupivacaine 0.75% or 3 ml of normal saline after completion of the vitreoretinal surgery, before the conjunctiva was sutured. The patients were randomized and were operated on by a single surgeon (KLG). A set protocol for postoperative oral analgesia in the recovery period was observed for all patients. This comprised oral Co-dydramol as a first line and oral Oromorph as a second line of medication. Patients' pain levels were recorded on a 3-point scale (mild, moderate and severe) by nursing staff at set intervals. These were at recovery, at 1 hour, at 3 hours and at 6 hours. Pain was classified as mild (requiring no analgesia), moderate (requiring oral Co-dydramol) or severe (requiring oral Oromorph). Fifteen patients (60%) received subtenon Bupivacaine and 10 (40%) received normal saline (controls). The surgeries included stand-alone external buckling procedures and vitrectomies with or without additional procedures. The duration of surgery varied from a minimum of 75 min to a maximum of 100 min, with a mean of 120 min. The types of surgeries and their duration were almost similar in the two groups. Four of the 15 patients (27%) receiving subtenon Bupivacaine 0.75% complained of some postoperative pain, which was mild to moderate in nature. Only two of these patients required additional analgesia. Nine of the 10 controls (90%) experienced postoperative pain and all of them needed analgesia. Most of them complained of pain within the first 3 hours after surgery. Five patients complained of severe pain and four of moderate pain. One patient had both nausea and vomiting. The efficacy of pre-emptive subtenon Bupivacaine 0.5% anaesthesia in retinal surgery was reported by Mahfouz & Nabawi (2002). However, to the best of our knowledge no other publication has documented the effect of subtenon Bupivacaine used after completion of retinal surgery, solely for the purpose of postoperative analgesia. In our series subtenon Bupivacaine 0.75% proved to be a safe and effective analgesic when used in patients undergoing vitreoretinal surgery under a general anaesthetic. Although the study groups were small, the results were statistically significant. However, a larger number of patients should be studied to validate the results of this research." @default.
• W1567355673 created "2016-06-24" @default.
• W1567355673 creator A5021061212 @default.
• W1567355673 creator A5052148843 @default.
• W1567355673 date "2005-02-16" @default.
• W1567355673 modified "2023-09-27" @default.
• W1567355673 title "Postoperative pain relief in vitreoretinal surgery with subtenon Bupivacaine 0.75%" @default.
• W1567355673 cites W2006678318 @default.
• W1567355673 cites W2073538232 @default.
• W1567355673 doi "https://doi.org/10.1111/j.1600-0420.2005.00246.x" @default.
• W1567355673 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15715573" @default.
• W1567355673 hasPublicationYear "2005" @default.
• W1567355673 type Work @default.
• W1567355673 sameAs 1567355673 @default.
• W1567355673 citedByCount "7" @default.
• W1567355673 countsByYear W15673556732012 @default.
• W1567355673 countsByYear W15673556732015 @default.
• W1567355673 countsByYear W15673556732019 @default.
• W1567355673 crossrefType "journal-article" @default.
• W1567355673 hasAuthorship W1567355673A5021061212 @default.
• W1567355673 hasAuthorship W1567355673A5052148843 @default.
• W1567355673 hasConcept C141071460 @default.
• W1567355673 hasConcept C168563851 @default.
• W1567355673 hasConcept C2777397205 @default.
• W1567355673 hasConcept C2778257484 @default.
• W1567355673 hasConcept C2780149897 @default.
• W1567355673 hasConcept C2781242345 @default.
• W1567355673 hasConcept C2781328992 @default.
• W1567355673 hasConcept C3019082958 @default.
• W1567355673 hasConcept C42219234 @default.
• W1567355673 hasConcept C71924100 @default.
• W1567355673 hasConceptScore W1567355673C141071460 @default.
• W1567355673 hasConceptScore W1567355673C168563851 @default.
• W1567355673 hasConceptScore W1567355673C2777397205 @default.
• W1567355673 hasConceptScore W1567355673C2778257484 @default.
• W1567355673 hasConceptScore W1567355673C2780149897 @default.
• W1567355673 hasConceptScore W1567355673C2781242345 @default.
• W1567355673 hasConceptScore W1567355673C2781328992 @default.
• W1567355673 hasConceptScore W1567355673C3019082958 @default.
• W1567355673 hasConceptScore W1567355673C42219234 @default.
• W1567355673 hasConceptScore W1567355673C71924100 @default.
• W1567355673 hasIssue "1" @default.
• W1567355673 hasLocation W15673556731 @default.
• W1567355673 hasLocation W15673556732 @default.
• W1567355673 hasOpenAccess W1567355673 @default.
• W1567355673 hasPrimaryLocation W15673556731 @default.
• W1567355673 hasRelatedWork W1555405038 @default.
• W1567355673 hasRelatedWork W1979319424 @default.
• W1567355673 hasRelatedWork W1987536037 @default.
• W1567355673 hasRelatedWork W2062508200 @default.
• W1567355673 hasRelatedWork W2296136517 @default.
• W1567355673 hasRelatedWork W2328610791 @default.
• W1567355673 hasRelatedWork W2466659596 @default.
• W1567355673 hasRelatedWork W3124388843 @default.
• W1567355673 hasRelatedWork W4213303435 @default.
• W1567355673 hasRelatedWork W4249371087 @default.
• W1567355673 hasVolume "83" @default.
• W1567355673 isParatext "false" @default.
• W1567355673 isRetracted "false" @default.
• W1567355673 magId "1567355673" @default.
• W1567355673 workType "article" @default.